Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion type Assertion NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_head.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion description "[Discoveries of frequent mutations involving BRAF(V600E), developmental and oncogenic roles for the microphthalmia-associated transcription factor (MITF) pathway, clinical efficacy of BRAF-targeted small molecules, and emerging mechanisms underlying resistance to targeted therapeutics represent just a sample of the findings that have created a striking inflection in the quest for clinically meaningful progress in the melanoma field.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_provenance.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion evidence source_evidence_literature NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_provenance.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion SIO_000772 22661227 NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_provenance.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion wasDerivedFrom befree-2016 NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_provenance.
- NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_assertion wasGeneratedBy ECO_0000203 NP986782.RAQjgr3cPKnBZ2LCxrNJ_8dMzIrUqnXVC2BJlwqme97lk130_provenance.